Conformation of the N-terminal segment of a monocysteine mutant of troponin I from cardiac muscle.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 9184156)

Published in Biochemistry on June 03, 1997

Authors

W J Dong1, M Chandra, J Xing, R J Solaro, H C Cheung

Author Affiliations

1: Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, 35294-2041, USA.

Articles citing this

Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis. J Biol Chem (2008) 1.29

Effects of PKA phosphorylation of cardiac troponin I and strong crossbridge on conformational transitions of the N-domain of cardiac troponin C in regulated thin filaments. Biochemistry (2007) 1.11

Structure of the inhibitory region of troponin by site directed spin labeling electron paramagnetic resonance. Proc Natl Acad Sci U S A (2002) 1.02

Structural studies of interactions between cardiac troponin I and actin in regulated thin filament using Förster resonance energy transfer. Biochemistry (2008) 0.98

Structural transition of the inhibitory region of troponin I within the regulated cardiac thin filament. Arch Biochem Biophys (2006) 0.95

Structural dynamics of C-domain of cardiac troponin I protein in reconstituted thin filament. J Biol Chem (2011) 0.94

An interdomain distance in cardiac troponin C determined by fluorescence spectroscopy. Protein Sci (2000) 0.84

Structural and kinetic effects of hypertrophic cardiomyopathy related mutations R146G/Q and R163W on the regulatory switching activity of rat cardiac troponin I. Arch Biochem Biophys (2012) 0.80

The heart-specific NH2-terminal extension regulates the molecular conformation and function of cardiac troponin I. Am J Physiol Heart Circ Physiol (2011) 0.80

Ca2+-induced PRE-NMR changes in the troponin complex reveal the possessive nature of the cardiac isoform for its regulatory switch. PLoS One (2014) 0.80

Fluorescence Based Characterization of Calcium Sensitizer Action on the Troponin Complex. Chem Biol Drug Des (2015) 0.78

FRET study of the structural and kinetic effects of PKC phosphomimetic cardiac troponin T mutants on thin filament regulation. Arch Biochem Biophys (2014) 0.78

Dynamic Equilibrium of cTnC's Hydrophobic Cleft and Its Modulation by Ca2+ Sensitizers and a Ca2+ Sensitivity blunting phosphomimic, cTnT(T204E). Bioconjug Chem (2017) 0.75

Articles by these authors

Multimodal representation of space in the posterior parietal cortex and its use in planning movements. Annu Rev Neurosci (1997) 3.58

Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (1995) 3.39

How stable is stable? Function versus community composition. Appl Environ Microbiol (1999) 3.08

A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant (2010) 3.05

Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res (1994) 2.91

Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature (1976) 2.65

Kinetic tuning of myosin via a flexible loop adjacent to the nucleotide binding pocket. J Biol Chem (1998) 2.62

Actin filaments in sensory hairs of inner ear receptor cells. J Cell Biol (1977) 2.46

The purification of cardiac myofibrils with Triton X-100. Biochim Biophys Acta (1971) 2.45

Phosphorylation of troponin I by protein kinase A accelerates relaxation and crossbridge cycle kinetics in mouse ventricular muscle. Circ Res (2001) 2.45

The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin. J Biol Chem (1982) 2.27

Method for isolation of adult mouse cardiac myocytes for studies of contraction and microfluorimetry. Am J Physiol (1996) 2.08

The hnRNP F protein: unique primary structure, nucleic acid-binding properties, and subcellular localization. Nucleic Acids Res (1994) 2.01

Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J Physiol (1999) 1.95

Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. Am J Transplant (2011) 1.93

The calcium and magnesium binding sites on cardiac troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J Biol Chem (1980) 1.89

Calcium requirements for cardiac myofibrillar activation. Circ Res (1974) 1.87

Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients. Ann Surg (1998) 1.85

Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart. Nature (1982) 1.83

Vanadate and phosphate ions reduce tension and increase cross-bridge kinetics in chemically skinned heart muscle. Biochim Biophys Acta (1981) 1.74

Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts. Biochem J (1988) 1.73

Laparoscopic management of benign solid and cystic lesions of the liver. Ann Surg (1999) 1.70

Ocular and orbital cysticercosis. Acta Ophthalmol Scand (2001) 1.66

Cardiac troponin I mutants. Phosphorylation by protein kinases C and A and regulation of Ca(2+)-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem (1995) 1.64

Calcium-induced structural transition in the regulatory domain of human cardiac troponin C. Biochemistry (1997) 1.61

Effects of diacetyl monoxime on cardiac excitation-contraction coupling. J Pharmacol Exp Ther (1985) 1.57

Occipital-parietal encephalopathy: a new name for an old syndrome. Pediatr Neurol (1997) 1.54

Breakdown and release of myofilament proteins during ischemia and ischemia/reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. Circ Res (1998) 1.54

Localization of regions of troponin I important in deactivation of cardiac myofilaments by acidic pH. J Mol Cell Cardiol (2001) 1.51

Molecular and physiological effects of alpha-tropomyosin ablation in the mouse. Circ Res (1998) 1.50

Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol (1999) 1.49

Critical appraisal of fine needle aspiration cytology in tuberculous lymphadenitis. Acta Cytol (1992) 1.48

Idiopathic arterial calcification of infancy: a case with prolonged survival. Pediatr Nephrol (1990) 1.46

Estimating the functional capabilities of sarcoplasmic reticulum in cardiac muscle. Calcium binding. Circ Res (1974) 1.46

Antibody to intermediate filaments of the cytoskeleton. Ann Rheum Dis (1982) 1.45

Calcium-binding properties of troponin C in detergent-skinned heart muscle fibers. J Biol Chem (1987) 1.44

Conformation of the regulatory domain of cardiac muscle troponin C in its complex with cardiac troponin I. J Biol Chem (1999) 1.43

Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture. Am J Clin Nutr (1997) 1.43

The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats. Toxicol Pathol (1993) 1.43

Halothane modifies ischemia-associated injury to the voltage-sensitive calcium channels in canine heart sarcolemma. Anesthesiology (1994) 1.41

Effect of radiation on cytokine and cytokine receptor messenger-RNA profiles in p53 wild and mutated human glioblastoma cell lines. Clin Invest Med (2001) 1.41

Non-Q-wave myocardial infarction-current status. J Assoc Physicians India (1988) 1.40

Effects of commonly used NSAID's on gastric mucosa. A clinico-endoscopic and histopathological study. J Assoc Physicians India (1990) 1.40

JEM spotlight: Environmental monitoring of airborne nanoparticles. J Environ Monit (2009) 1.40

Inhibition of the activation and troponin calcium binding of dog cardiac myofibrils by acidic pH. Circ Res (1984) 1.39

Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction. Circ Res (1999) 1.39

Screening of sputum: an experience in a tertiary care hospital. J Assoc Physicians India (1999) 1.39

HIV infection in the blood donors of Delhi, India: 1 1/2 years' experience. J Acquir Immune Defic Syndr (1991) 1.39

Contractile deactivation and uncoupling of crossbridges. Effects of 2,3-butanedione monoxime on mammalian myocardium. Circ Res (1991) 1.38

Kinetic studies of calcium binding to the regulatory site of troponin C from cardiac muscle. J Biol Chem (1996) 1.37

Trp(56) of rac1 specifies interaction with a subset of guanine nucleotide exchange factors. J Biol Chem (2001) 1.37

Correlation between myofilament response to Ca2+ and altered dynamics of contraction and relaxation in transgenic cardiac cells that express beta-tropomyosin. Circ Res (1999) 1.37

Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J Clin Invest (1990) 1.37

A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol (2001) 1.37

Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T. Am J Physiol Heart Circ Physiol (2001) 1.36

Modulation of Ca2+ control of dog and rabbit cardiac myofibrils by Mg2+. Comparison with rabbit skeletal myofibrils. Circ Res (1976) 1.35

Donovanosis - a histopathological study. Indian J Pathol Microbiol (1981) 1.33

The N-terminal region of troponin T is essential for the maximal activation of rat cardiac myofilaments. J Mol Cell Cardiol (1999) 1.31

Relative capabilities of sarcoplasmic reticulum in fast and slow mammalian skeletal muscles. J Physiol (1977) 1.30

Quantification of the calcium-induced secondary structural changes in the regulatory domain of troponin-C. Protein Sci (1994) 1.30

Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C. Biochemistry (1997) 1.29

Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice. J Physiol (2001) 1.29

Shrinkage of the esophagus after resection for carcinoma. Ann Surg (1986) 1.27

Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I. J Physiol (2000) 1.26

Kocher Debre Semelaigne syndrome: regression of pesudohypertrophy of muscles on thyroxine. Arch Dis Child (2002) 1.26

NMR analysis of cardiac troponin C-troponin I complexes: effects of phosphorylation. FEBS Lett (1999) 1.25

The C terminus of cardiac troponin I is essential for full inhibitory activity and Ca2+ sensitivity of rat myofibrils. J Biol Chem (1997) 1.24

Amifostine reduces lung vascular permeability via suppression of inflammatory signalling. Eur Respir J (2008) 1.24

Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999-2010. J Viral Hepat (2012) 1.24

Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India. J Assoc Physicians India (2007) 1.24

Thyroxine-induced redistribution of isoenzymes of rabbit ventricular myosin. Circ Res (1982) 1.24

The hill coefficient for the Ca2+-activation of striated muscle contraction. Biophys J (1984) 1.23

Translocation of Thy-1 antigen and a fluorescent lipid probe during lymphoblastoid cell interaction with Mycoplasma hyorhinis. Rev Infect Dis (1982) 1.23

Epidemiological study of ocular trauma in an urban slum population in Delhi, India. Indian J Ophthalmol (2008) 1.22

Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res (1999) 1.21

Equilibrium studies of kinesin-nucleotide intermediates. J Biol Chem (1996) 1.21

Differential regulation of cardiac actomyosin S-1 MgATPase by protein kinase C isozyme-specific phosphorylation of specific sites in cardiac troponin I and its phosphorylation site mutants. Biochemistry (1996) 1.20

Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions. J Physiol (2001) 1.20

The calcium binding properties of phosphorylated and unphosphorylated cardiac and skeletal myosins. J Biol Chem (1979) 1.20

Kinetic and spectroscopic evidence for three actomyosin:ADP states in smooth muscle. J Biol Chem (2000) 1.18

Isolation of cardiac myofibrils and myosin light chains with in vivo levels of light chain phosphorylation. Biochim Biophys Acta (1979) 1.17

Inotropic responses to isoproterenol and phosphodiesterase inhibitors in intact guinea pig hearts: comparison of cyclic AMP levels and phosphorylation of sarcoplasmic reticulum and myofibrillar proteins. Circ Res (1989) 1.17

Exchange of beta- for alpha-tropomyosin in hearts of transgenic mice induces changes in thin filament response to Ca2+, strong cross-bridge binding, and protein phosphorylation. J Biol Chem (1996) 1.17

The effect of acidic pH on the ATPase activity and troponin Ca2+ binding of rabbit skeletal myofilaments. J Biol Chem (1984) 1.17

Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model. Transplantation (1999) 1.16

Three sets of actin filaments in sensory cells of the inner ear. Identification and functional orientation determined by gel electrophoresis, immunofluorescence and electron microscopy. J Neurocytol (1981) 1.14

Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone. Circ Res (1988) 1.13

Structure of the C-domain of human cardiac troponin C in complex with the Ca2+ sensitizing drug EMD 57033. J Biol Chem (2001) 1.13

Phosphorylation-induced distance change in a cardiac muscle troponin I mutant. Biochemistry (1997) 1.12